Currently out of the existing stock ratings of James Mcilree, 41 are a BUY (85.42%), 4 are a HOLD (8.33%), 3 are a SELL (6.25%).

James Mcilree

Work Performance Price Targets & Ratings Chart

Analyst James Mcilree, currently employed at DAWSON JAMES, carries an average stock price target met ratio of 53.25% that have a potential upside of 46.06% achieved within 494 days.

James Mcilree’s has documented 81 price targets and ratings displayed on 12 stocks. The coverage is on Consumer Cyclical, Technology sectors.

Most recent stock forecast was given on BYRN, Byrna Technologies at 27-Sep-2023.

Wall Street Analyst James Mcilree

Analyst best performing recommendations are on VUZI (VUZIX CORP CMN STK).
The best stock recommendation documented was for VUZI (VUZIX CORP CMN STK) at 5/21/2019. The price target of $10 was fulfilled within 581 days with a profit of $7.6 (316.67%) receiving and performance score of 5.45.

Average potential price target upside

BYRN Byrna Technologies CRKN Crown Electrokinetics Corp. FUV Arcimoto GSAT Globalstar KVHI KVH Industries SMSI Smith Micro Software SRAX SRAX VUZI Vuzix Corp Cmn Stk OBLG Oblong ORBC ORBCOMM SUNW Sunworks XXII 22nd Century Group

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$17

$-1.32 (-7.21%)

$8

7 months 13 days ago
(08-Apr-2024)

6/10 (60%)

$2.03 (13.56%)

332

Hold

$8

1 years 1 months 25 days ago
(27-Sep-2023)

2/6 (33.33%)

$4.11 (105.66%)

452

Hold

$7.25

1 years 1 months 25 days ago
(27-Sep-2023)

4/4 (100%)

$3.36 (86.38%)

530

Buy

$14

$2.19 (18.54%)

$26.5

2 years 8 months 30 days ago
(22-Feb-2022)

1/2 (50%)

$5.85 (71.78%)

14

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by James Mcilree?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?